Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Leeds
A double-blind, randomised, placebo-controlled trial of eicosapentaenoic acid (EPA), in the free fatty acid form, 2g daily in patients who will undergo liver resection surgery for colorectal cancer liver metastases.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age greater than or equal to 18 years
Either sex
Liver resection deemed clinically appropriate for management of metastatic colorectal cancer
Duration between decision to perform liver resection and surgery greater than 2 weeks
Ability to give written informed consent and follow study protocol
Telephone contact possible
You may not be if
Neo-adjuvant chemotherapy for colorectal cancer (CRC) liver metastasis
Chemotherapy for any cancer in the previous 3 months
Known bleeding diathesis or anticoagulation therapy
Fish or seafood allergy
Use of fish oil supplements (eg. cod liver oil) and unwilling to stop for the duration of the study
Pregnancy
Non-aspirin non-steroidal anti-inflammatory (NSAID) or corticosteroid use
Renal impairment (serum creatinine \>150)
Active inflammatory disease (e.g. Inflammatory Bowel Disease, Rheumatoid Arthritis).
